Remote Sales Team = 104% TRx Growth - Amplity

Amplity Medical →

Outsourcing global clinical 
& medical engagement for accelerated drug approval 
& acceptance

Amplity Sales →

Flexible, scalable sales teams for rapid product launch 
& lifecycle management

Amplity Intel →

Real-time patient-level insights powered by a
one-of-a-kind comprehensive
qualitative database + platform — AnswerY™

Amplity Comms →

Premium content & audience access to critical oncology care networks

Amplity Learn →

Continuous growth for teams and individuals led by pharma industry experts

Amplity Sales

Neurology Psychiatry

Remote Sales Team = 104% TRx Growth

Download PDF

High-priority target success: Triple-digit TRx growth in 13 weeks with remote sales strategy.

OUR TASK

A midsized biopharma needed to re-engage 3000+ HCPs, focusing on high-priority accounts no longer covered by field reps. Amplity’s remote sales team pilot program achieved 104% TRx growth in 13 weeks through precision outreach, demonstrating that remote teams can surpass business objectives without disrupting field sales efforts.

Download PDF

The Power of This Partnership

104%

TRx Growth In 13 Weeks

The Ask

CLIENT

U.S.

Mid-Sized BioPharma

Re-Engage Key Accounts

Client needs to drive growth in high-priority targets no longer being called on by field sales team.

Pilot Remote Sales Team

Via pilot program, understand if a remote sales team can drive sales with precision and no field crossover.

The Approach

TOOLS

Remote Team

Build Remote Team

Deploy remote reps to target 3000+ HCPs, with one-third designated as high-priority targets.

Refine Territory Alignment For Best Coverage

Overlay field territories to ensure strategic coverage of high-value targets not covered by the field.

Track Outreach Success

Call on high-priority targets independent of the field and only track for growth if the rep had detailed the HCP.

The Results

OUTCOME

Business Objectives Exceeded

Revenue Growth

Rx Uptake Boom

104% TRx growth for high-priority targets over first 13 weeks of pilot.

Strategic Targeting

Demonstrated the ability to successfully drive sales without field support.

Read Next

View All

View All

Intel

Neurology, Rare Disease

•

Intel

AnswerY Delivers 19:1 ROI

January 8, 2025

Research

AI + NLP, Neurology, Rare Disease, RWE + HEOR

•

Research

Exploring The Clinical Burden Of Dravet Syndrome & Lennox-Gastaut Syndrome

May 30, 2025

Research

AI + NLP, Neurology, Rare Disease, RWE + HEOR

•

Research

NLP Unlocks Patterns In Myasthenia Gravis Progression

May 21, 2025